---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-006953"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:44:02.332105+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q3 net loss $716K; plans to refranchise majority of corporate clinics

## Summary
- Revenue $29.5M (+11% YoY); net loss $0.05/sh vs income $0.05/sh in Q3 2022.
- Operating loss $898K vs operating income $732K; Adj EBITDA $2.9M vs $3.1M.
- System-wide sales +8% to $119.3M; comp sales flat; total clinics 914.
- Board authorized plan to refranchise/sell majority of corporate-owned clinics.
- Reaffirmed FY 2023 guidance: revenue $115-118M, Adj EBITDA $11-12.5M.

## SEC filing metadata
- accession: 0001171843-23-006953
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/0001171843-23-006953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/f8k_091123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-006953
- JSON: https://secwatch.observer/filing/0001171843-23-006953.json
- Plain text: https://secwatch.observer/filing/0001171843-23-006953.txt

## Key facts
- Earnings Releases
  JOINT Corp reported the quarter ended September 30, 2023 results: revenue $29.5 million, net income net loss of $716,000, or $0.05 per share, EPS $0.05 per share. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2023
  - Revenue: $29.5 million
  - Net income: net loss of $716,000, or $0.05 per share
  - EPS: $0.05 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: of chiropractic clinics, reported its financial results for the quarter ended September 30, 2023. Financial Highlights: Q3 2023 Compared to Q3 2022 ● Grew revenue by 11% to $29.5 million. ● Reported operating loss of $898,000, compared to operating income of $732,000. ● Reported net loss of $716,000, including a loss on disposition or impairment related to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1612630/000117184323006953/0001171843-23-006953-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.